Clinical Trial Update: Pharmacokinetics (PK), Pharmacodynamics (PD), Safety, Tolerability of Multiple Dose Regimens of MT-3724 for the Treatment of Patients With Relapsed Chronic B-cell Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 trial of MT-3724 for relapsed chronic lymphocytic leukemia or small lymphocytic lymphoma has been withdrawn; no results are reported due to the withdraw…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• MT-3724

Snippet

Sponsor: Molecular Templates, Inc. | Conditions: Chronic B-cell Lymphocytic Leukemia, Small Lymphocytic Leukemia | Phase 1 | Status: WITHDRAWN